CD8A and myeloid sarcoma: However, another study10 found no differences in the CD8+ T cell frequencies between patients with MS and healthy controls for seven HLA-B7 restricted EBV peptides, including one of the peptides found by Höllsberg and colleagues9 to elicit an increased response.